Kodiak Sciences Inc. (KOD) PT Lowered to $138 at BMO Capital

March 1, 2021 3:57 PM EST
Get Alerts KOD Hot Sheet
Price: $116.00 +2.34%

Rating Summary:
    8 Buy, 5 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 16 | Down: 18 | New: 32
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

BMO Capital analyst Matthew Luchini lowered the price target on Kodiak Sciences Inc. (NASDAQ: KOD) to $138.00 (from $148.00) while maintaining a Market Perform rating.

The analyst commented, "Kodiak reported 4Q20 GAAP EPS of ($0.97), lower than our ($0.77) and consensus' ($0.53), due to higher operating expenses. While the KSI-301 Phase 1b data presented at Angiogenesis provides good proof of concept, we believe current levels reflect KSI-301's progress to date, and we remain on the sidelines ahead of pivotal top-line data readouts expected in 2022. We update our model for 4Q20 results and lower our target price to $138 on higher spending expectations. Maintain Market Perform rating."

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change

Related Entities

BMO Capital